Elevating real-world data (RWD) to the status of regulatory-grade evidence will bring both opportunity and challenges to the industry.
David Lazerson
Advertisement
David Lazerson is Co-founder and CEO of Briya, a healthcare technology company supporting vital medical and biopharma research and innovation through proprietary AI and data solutions. He has over a decade of experience in cybersecurity and health IT leadership. Prior to co-founding Briya, David served as CEO of Axioma Cyber Services.
Articles by David Lazerson
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
How Are Regulatory Factors Impacting Biosimilars
2
Obsidian Therapeutics and Galera Therapeutics Enter $350 Million Merger Agreement
3
Pharma Finance Roundup: Platform Innovation Drives Biotech Investment Across Oncology and Immunology
4
A New Standard for Copay Excellence: Q&A with Brian Laird
5